Athira Pharma, Inc. (ATHA) Tops Q2 EPS by 4c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.70), $0.04 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• MSC Industrial (MSM) Tops Q3 EPS by 17c, Beats on Revenue
• RPM International (RPM) Declares $0.54 Quarterly Dividend; 1.9% Yield
• Karman Space & Defense (KRMN) Added to Citi 90-Day Upside Catalyst Watch List